Navigation Links
Genesis Biopharma Announces Letter to Shareholders Posted to Website
Date:8/30/2011

href="http://www.ncbi.nlm.nih.gov/pubmed/21498393">http://www.ncbi.nlm.nih.gov/pubmed/21498393.  In partnership with key scientists and clinicians at these cancer medical centers, Genesis Biopharma is developing commercial-scale manufacturing, quality and regulatory systems to allow Contego to be delivered to patients as the standard care autologous cell therapy.

We recently partnered with the NCI by entering into a cooperative research and development agreement (CRADA).  The principal investigator is Steven A. Rosenberg, M.D., Ph.D., Chief, Surgery Branch, Center for Cancer Research of the NCI. While the ACT using tumor infiltrating lymphocytes (TIL) therapy approach is proprietary to the NCI, the principal goal of this CRADA is for Genesis and the NCI to collaborate on the development and evaluation of ACT/TIL for the treatment of patients with metastatic melanoma.  

Specifically this CRADA addresses:  (1) the in vitro development of improved methods for the large-scale generation and selection of TIL with anti-tumor reactivity from patients with metastatic melanoma based on ACT therapies developed by and proprietary to the NCI Surgery Branch; (2) the development of these approaches for large-scale TIL production that are in accord with Good Manufacturing Practice suitable for use in treating patients with metastatic melanoma; and, (3) the development of clinical trials using these improved methods of large-scale TIL production as well as improved patient preparative regimens with the goal of commercializing the ACT/TIL therapy approach for treating patients with metastatic melanoma.

Contego is a ready-to-infuse autologous cell therapy using tumor infiltrating lymphocytes that, following approval by the U.S. Food and Drug Administration, will be administered as an in-patient therapy at major cancer medical centers.  

Our strategy of working in partnership with major cancer medical centers offers seve
'/>"/>

SOURCE Genesis Biopharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ThermoGenesis Names Former Applied Imaging CEO Robin Stracey to Board of Directors, Replacing Dr. Mahendra Rao
2. Mummy News: Genesis Medical Imaging Mobile CT Scan Unit Helps Chicagos Field Museum Discover Ancient Secrets
3. Genesis Biopharma to Hold Business Update Conference Call on June 29
4. ThermoGenesis Announces Webcast of Presentation at OnemedForum Conference
5. Nature Article Implicates microRNAs in the Pathogenesis of Obesity and Type 2 Diabetes
6. Reportlinker Adds Triple Analysis: Lung Cancer, Lymphoma and Angiogenesis
7. CryoLife Announces Completion of Acquisition of Cardiogenesis
8. CryoLife Announces Final Results of Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation
9. ThermoGenesis Reports Third Quarter Fiscal 2011 Results; Major Progress Achieved in China & India
10. Cardiogenesis Reports First Quarter 2011 Results
11. CryoLife Completes Tender Offer for 49.9 Percent of the Outstanding Shares of Cardiogenesis Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... SAN DIEGO , July 29, 2014 /PRNewswire/ ... of Nancy Thornberry to its board ... and franchise head, Diabetes and Endocrinology for Merck ... research, strategy and overall pipeline management in diabetes, ... scientist, initiated and co-led the program that resulted ...
(Date:7/29/2014)... Colo. , July 29, 2014  Encision Inc. ... that prevents dangerous stray electrosurgical burns in minimally invasive ... first quarter ended June 30, 2014. The ... a quarterly net loss of $202 thousand, or $(0.02) ... $2.682 million for a net loss of $311 thousand, ...
(Date:7/28/2014)... -- Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ) ... audio webcast to discuss financial results for the second quarter ... 31, 2014 at 4:30 p.m. ET. Conference ... 31, 2014 Time: 4:30 PM ET Listen via Internet: ... A webcast replay will be available on the Pharmacyclics ...
Breaking Medicine Technology:Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 2Abide Therapeutics Appoints Nancy Thornberry to Board of Directors 3Encision Reports First Quarter Fiscal Year 2015 Results 2Encision Reports First Quarter Fiscal Year 2015 Results 3Encision Reports First Quarter Fiscal Year 2015 Results 4Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014 2
... Calif., Sept. 13, 2011 Edison Pharmaceuticals, Inc. announced ... Financing. Capital raised will fund US and European approval ... Terms of the financing were not disclosed. ... Pharmaceuticals is a patient- and physician-founded company devoted to ...
... a leader in Quality of Daily Life Solutions announced ... the agreement, Sodexo will offer technology-enabled solutions by Healthsense ... Sodexo,s current offerings to realize their vision of improved ... communities they serve.   Healthsense is an ...
Cached Medicine Technology:Sodexo Partners with Healthsense to Offer Seniors Technology-Enabled Solutions that Improve Quality of Daily Life 2Sodexo Partners with Healthsense to Offer Seniors Technology-Enabled Solutions that Improve Quality of Daily Life 3
(Date:7/29/2014)... Summer is here, and that means it’s time to soak up ... pool or laying out on the beach. However, warm weather can ... is here to help pet owners protect their dogs from these ... completely keep fleas and ticks at bay, but there are steps ... coming into contact with fleas and ticks. , Flea eggs can ...
(Date:7/29/2014)... Bret Busacker , a partner in ... been appointed to the Board of Directors for the ... an experienced business attorney with a focus on employee ... a wide spectrum of topics regarding equity and incentive ... concerns. His clients include public and private businesses, governmental ...
(Date:7/29/2014)... The report, “Heat Transfer Fluids Market ... Glycol Fluids, & Others), by Application (Oil & Gas, ... - Trends & Forecasts to 2019” defines and segments ... and forecast of the global consumption in terms of ... 64 figures spread through 199 page sand in-depth TOC ...
(Date:7/29/2014)... News) -- Quitting smoking is harder for people with ... make it more difficult to ride out the anxiety, cravings ... cold turkey, scientists found. But extra exercise -- even just ... "The review should be seen as a call to ... the department of exercise science at Concordia University in Montreal, ...
(Date:7/29/2014)... 29, 2014 More Zeppelin than Zen, the ... will soon be having a complete renovation and, upon its ... rock one’s body and soul. , The Rock Spa® will ... in job opportunities for experienced hair and nail stylists. Both ... time team members will be given full medical and health ...
Breaking Medicine News(10 mins):Health News:Protect Dogs From Fleas and Ticks During the Summer 2Health News:Holland & Hart Partner Brett Busacker Appointed to Board of Directors for American Red Cross of Greater Idaho 2Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 2Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 3Health News:Heat Transfer Fluids Market Expected to Grow 641,218.19 Tons by 2019 – New Report by MarketsandMarkets 4Health News: Extra Exercise Could Help Depressed Smokers Quit: Study 2Health News:Rock Spa® at Seminole Hard Rock Hotel & Casino Tampa Prepares for Expansion 2
... after having their tonsils and adenoids removed to treat ... over time they may relapse or even worsen. African-American ... from Cincinnati Childrens Hospital Medical Center. , Adenotonsillectomy ... from about 19 per 10,000 in Canada to 115 ...
... 14 Murad, where skincare,meets healthcare(R), today ... the,company,s new Vice President of Global Marketing ... pivotal lead in driving brand growth and ... market,opportunities, driving product development, increasing brand profitability,and ...
... Policy Changes in Handling Credit ... ... today that he has reached a settlement with TransUnion over his,lawsuit against ... TransUnion is the first of six credit reporting companies and banks,which ...
... - Body Mass Index (BMI), the measure of a person,s ... effective prognostic tool for specific types of breast cancer, according ... Cancer Center. , The study, published in the March 15 ... breast cancer (LABC) and inflammatory breast cancer (IBC) with high ...
... PHILADELPHIA Women with breast cancer have more aggressive ... or obese, according to findings published in the March ... the American Association for Cancer Research. , The ... disease, said Massimo Cristofanilli, MD, associate professor of medicine ...
... MNKD ), focused on discovering, developing and,commercializing treatments ... at the Cowen and Company Healthcare Conference on March ... Place Hotel in Boston, MA., Interested parties can ... the,presentation in the Investor Relations section of the Company,s ...
Cached Medicine News:Health News:The ABCs of childhood z's: Snoring may be chronic despite surgery 2Health News:Murad, Inc., Hires Lori Jacobus as Vice President of Global Marketing 2Health News:Leukemia Survivor Reaches Landmark Settlement With TransUnion in ID Theft Case 2Health News:Body Mass Index may serve as prognostic tool for advanced, aggressive breast cancers 2Health News:Body Mass Index may serve as prognostic tool for advanced, aggressive breast cancers 3Health News:Breast cancer more aggressive among obese women 2
Colloidal Gold Conjugated, Protein A - 12 OD...
Polyester ribbons (3) impregnated with different OD values of conjugated Protein G...
Colloidal Gold Conjugated, Protein G - 12 OD...
Colloidal Gold Sol, 40 nm - 50 OD, 1 ml, Gold Sol Nanoparticles - not boiled, not centrifuged...
Medicine Products: